查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1588367

毒理學測試外包市場規模、佔有率、趨勢分析報告：按方法、按 GLP、按最終用途、按地區和細分市場預測，2025-2030 年

Toxicity Testing Outsourcing Market Size, Share & Trends Analysis Report By Method (In Vitro, In Vivo), By GLP (GLP, Non GLP), By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

毒理學測試外包市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，預計到2030年，全球毒性測試外包市場規模將達到63.6億美元，2025年至2030年複合年成長率為9.52%。

臨床前測試的流失率不斷增加，刺激了對提供端到端服務（包括毒理學測試服務）的臨床前外包的需求。此外，製藥和生物製藥公司的成長、技術創新的增加、研發的增加以及對動物使用的道德擔憂的增加正在推動市場擴張。

COVID-19 對毒理學測試外包市場產生了重大影響。在這場危機期間，疫苗、醫療設備和生物製藥的合約研究和製造服務供應商在滿足製藥公司、生物技術公司和其他最終用戶的需求方面發揮了關鍵作用。自 2019年終以來，這些組織一直在積極致力於開發可用於治療輕度 COVID-19 患者的醫療保健產品。這些產品在每個階段都需要進行毒性測試，以評估其安全性和有效性，從而促進市場成長。

製藥和生物製藥行業的公司在一個越來越難以理解的環境中運作。許多治療領域的治療方法的改進以及新型治療方法的出現，例如基因標靶治療、生物製藥、幹細胞療法和其他治療方法，正在使開發和監管途徑變得更加複雜。為了開發安全有效的治療方法，需要在每個步驟進行毒性測試，這推動了市場的成長。

毒理學測試外包市場報告亮點

  • 2024年，體外細分市場佔據主導地位，佔收益佔有率的57.97%。這一成長預計將受到多種因素的推動，包括產品開發活動的增加、研發費用的增加、毒理學意識的提高以及前臨床開發平臺的增加。
  • 到 2024 年，GLP 細分市場將擁有最大的市場佔有率。包括安全藥理學、遺傳毒性和重複毒性在內的臨床試驗對於人類安全暴露至關重要，並且必須按照 GLP 標準進行。
  • 2024年，製藥和生物製藥公司以61.41%的收益佔有率主導市場。
  • 2024年，北美以43.13%的最大佔有率主導全球毒理學檢測外包市場。這是由於美國和加拿大製藥業的成長。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章毒理學測試外包市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場推動要素分析
    • 市場限制因素分析
  • 市場分析工具
    • 波特五力分析
    • PESTEL分析
    • COVID-19 影響分析

第4章毒理學檢測外包市場：方法估算與趨勢分析

  • 細分儀表板
  • 全球毒理學測試外包市場：方法學變異分析
  • 2018-2030年毒性檢測外包規模及趨勢分析（分方法）
  • In vitro
  • In vivo

第5章毒理學檢測外包市場：GLP預估及趨勢分析

  • 細分儀表板
  • 全球毒理學測試外包市場：GLP變異分析
  • 全球毒理學測試外包規模及趨勢分析，GLP，2018-2030
  • GLP
  • 非GLP

第6章毒理學測試外包市場：最終用途估計與趨勢分析

  • 細分儀表板
  • 全球毒理學測試外包市場：最終用途變異分析
  • 2018-2030 年全球毒理學測試外包規模和趨勢分析（按最終用途）
  • 製藥和生物製藥公司
  • 學術研究所
  • 其他

第7章毒理學測試外包市場：區域估計和趨勢分析

  • 2023 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭格局

  • 公司分類
  • 2023 年企業市場分析
  • 公司簡介
    • Eurofins Scientific
    • SGS SA
    • Charles River Laboratories
    • Thermo Fisher Scientific, Inc
    • Intertek Group plc
    • Catalent, Inc
    • ICON plc
    • Med pace
    • Wuxi AppTec
    • Labcorp Drug Development
Product Code: GVR-4-68039-978-8

Toxicity Testing Outsourcing Market Growth & Trends:

The global toxicity testing outsourcing market size is expected to reach USD 6.36 billion by 2030, registering a CAGR of 9.52% from 2025 to 2030, according to a new report by Grand View Research, Inc. The increasing attrition rate in preclinical studies is stimulating demand for the outsourcing of preclinical studies to the CROs, which offer end-to-end services including toxicology testing services. Also, rising growth and innovation in pharmaceutical and biopharmaceutical companies, augment in R&D, and increasing ethical concerns about animal use are driving the enlargement of the market.

COVID-19 has significantly impacted the market for toxicity testing outsourcing. During the crisis, vaccine, medical device, and biologic contract research and manufacturing service providers played a predominant role in meeting the needs of pharmaceutical companies, biotech companies, and other end users. These organizations have been actively working towards the development of healthcare products that can be used as a treatment for patients, suffering from COVID-19 with mild symptoms, since the end of 2019. And these products require toxicity testing at each stage to assess safety and effectiveness, thus contributing to market growth.

Companies in the pharmaceutical and biopharmaceutical industries operate in an environment that is becoming more complex to understand. Improvements in many therapeutic areas, as well as the emergence of new types of therapies such as genetically targeted therapies, biologics, stem cell therapies, and other treatment modalities, have resulted in more complex development and regulatory pathways. To develop a treatment that is secure and efficient, it is necessary to do toxicity testing at each stage, which is boosting the market's growth.

Toxicity Testing Outsourcing Market Report Highlights:

  • In 2024, the in vitro segment dominated the market, accounting for a revenue share of 57.97%. This growth is anticipated to be fueled by several factors, including increased product development activities, rising R&D spending, growing toxicological awareness, and an increasing preclinical pipeline.
  • GLP segment accounted for the larger market share in 2024. Clinical studies, including safety pharmacology, genotoxicity, and repeated toxicity, are mandatory for safe exposure to humans and must be performed as per the standards of GLP.
  • In 2024, the pharmaceutical and biopharmaceutical companies segment dominated the market, accounting for a revenue share of 61.41%.
  • North America toxicity testing outsourcing market dominated the global market in 2024 with the largest share of 43.13%. This can be attributed to the growth of the pharmaceutical industries in the U.S. and Canada.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity Flow Analysis
    • 1.6.2. Bottom-up Approach
  • 1.7. List of Secondary Sources
  • 1.8. List of Abbreviations
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Toxicity Testing Outsourcing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Growth and innovation in the life sciences industry
      • 3.2.1.2. Increased investment in research and development
      • 3.2.1.3. Increasing Complexity in Research and Development
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Monitoring issues and lack of standardization
  • 3.3. Market Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Toxicity Testing Outsourcing Market: Method Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Toxicity Testing Outsourcing Market; Method Movement Analysis
  • 4.3. Global Toxicity Testing Outsourcing Size & Trend Analysis, by Method, 2018 to 2030 (USD Million)
  • 4.4. In vitro
    • 4.4.1. In vitro market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. In vivo
    • 4.5.1. In vivo market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Toxicity Testing Outsourcing Market: Glp Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Toxicity Testing Outsourcing Market; Glp Movement Analysis
  • 5.3. Global Toxicity Testing Outsourcing Size & Trend Analysis, by Glp, 2018 to 2030 (USD Million)
  • 5.4. GLP
    • 5.4.1. GLP market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Non GLP
    • 5.5.1. Non GLP market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Toxicity Testing Outsourcing Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Toxicity Testing Outsourcing Market; End Use Movement Analysis
  • 6.3. Global Toxicity Testing Outsourcing Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 6.4. Pharmaceutical and Biopharmaceutical Companies
    • 6.4.1. Pharmaceutical and biopharmaceutical companies market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Academic and Research Institutes
    • 6.5.1. Academic and research institutes market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Others
    • 6.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Toxicity Testing Outsourcing Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2023 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. North America
    • 7.3.1. North America Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Competitive scenario
      • 7.3.2.3. Regulatory framework
      • 7.3.2.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Key country dynamics
      • 7.3.3.2. Competitive scenario
      • 7.3.3.3. Regulatory framework
      • 7.3.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.4. Mexico
      • 7.3.4.1. Key country dynamics
      • 7.3.4.2. Competitive scenario
      • 7.3.4.3. Regulatory framework
      • 7.3.4.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4. Europe
    • 7.4.1. Europe Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.4.2. UK
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Competitive scenario
      • 7.4.2.3. Regulatory framework
      • 7.4.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.3. Germany
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Competitive scenario
      • 7.4.3.3. Regulatory framework
      • 7.4.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.4. France
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Competitive scenario
      • 7.4.4.3. Regulatory framework
      • 7.4.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.5. Italy
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Competitive scenario
      • 7.4.5.3. Regulatory framework
      • 7.4.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.6. Spain
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Competitive scenario
      • 7.4.6.3. Regulatory framework
      • 7.4.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.7. Denmark
      • 7.4.7.1. Key country dynamics
      • 7.4.7.2. Competitive scenario
      • 7.4.7.3. Regulatory framework
      • 7.4.7.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.8. Sweden
      • 7.4.8.1. Key country dynamics
      • 7.4.8.2. Competitive scenario
      • 7.4.8.3. Regulatory framework
      • 7.4.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.9. Norway
      • 7.4.9.1. Key country dynamics
      • 7.4.9.2. Competitive scenario
      • 7.4.9.3. Regulatory framework
      • 7.4.9.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Asia Pacific Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.2. Japan
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Competitive scenario
      • 7.5.2.3. Regulatory framework
      • 7.5.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.3. China
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Competitive scenario
      • 7.5.3.3. Regulatory framework
      • 7.5.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.4. India
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Competitive scenario
      • 7.5.4.3. Regulatory framework
      • 7.5.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.5. Australia
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Competitive scenario
      • 7.5.5.3. Regulatory framework
      • 7.5.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.6. South Korea
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Competitive scenario
      • 7.5.6.3. Regulatory framework
      • 7.5.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.7. Thailand
      • 7.5.7.1. Key country dynamics
      • 7.5.7.2. Competitive scenario
      • 7.5.7.3. Regulatory framework
      • 7.5.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Latin America Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.6.2. Brazil
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Competitive scenario
      • 7.6.2.3. Regulatory framework
      • 7.6.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Competitive scenario
      • 7.6.3.3. Regulatory framework
      • 7.6.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. MEA
    • 7.7.1. MEA Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.7.2. South Africa
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Competitive scenario
      • 7.7.2.3. Regulatory framework
      • 7.7.2.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. Saudi Arabia
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Competitive scenario
      • 7.7.3.3. Regulatory framework
      • 7.7.3.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.4. UAE
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Competitive scenario
      • 7.7.4.3. Regulatory framework
      • 7.7.4.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.5. Kuwait
      • 7.7.5.1. Key country dynamics
      • 7.7.5.2. Competitive scenario
      • 7.7.5.3. Regulatory framework
      • 7.7.5.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Company Market Position Analysis, 2023
  • 8.3. Company Profiles
    • 8.3.1. Eurofins Scientific
      • 8.3.1.1. Company overview
      • 8.3.1.2. Financial performance
      • 8.3.1.3. Service benchmarking
      • 8.3.1.4. Strategic initiatives
    • 8.3.2. SGS SA
      • 8.3.2.1. Company overview
      • 8.3.2.2. Financial performance
      • 8.3.2.3. Service benchmarking
      • 8.3.2.4. Strategic initiatives
    • 8.3.3. Charles River Laboratories
      • 8.3.3.1. Company overview
      • 8.3.3.2. Financial performance
      • 8.3.3.3. Service benchmarking
      • 8.3.3.4. Strategic initiatives
    • 8.3.4. Thermo Fisher Scientific, Inc
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Service benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Intertek Group plc
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Service benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Catalent, Inc
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Service benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. ICON plc
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Service benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Med pace
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Service benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Wuxi AppTec
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Service benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Labcorp Drug Development
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Service benchmarking
      • 8.3.10.4. Strategic initiatives

List of Tables

  • Table 1. List of Tables
  • Table 2. List of Secondary Sources
  • Table 3. List of Abbreviations
  • Table 4. Global Toxicity Testing Outsourcing, by Method, 2018 - 2030 (USD Million)
  • Table 5. Global Toxicity Testing Outsourcing, by Glp, 2018 - 2030 (USD Million)
  • Table 6. Global Toxicity Testing Outsourcing, by End Use, 2018 - 2030 (USD Million)
  • Table 7. Global Toxicity Testing Outsourcing, by Region, 2018 - 2030 (USD Million)
  • Table 8. North America Toxicity Testing Outsourcing, by Country, 2018 - 2030 (USD Million)
  • Table 9. North America Toxicity Testing Outsourcing, by Method, 2018 - 2030 (USD Million)
  • Table 10. North America Toxicity Testing Outsourcing, by Glp, 2018 - 2030 (USD Million)
  • Table 11. North America Toxicity Testing Outsourcing, by End Use, 2018 - 2030 (USD Million)
  • Table 12. U.S. Toxicity Testing Outsourcing, by Method, 2018 - 2030 (USD Million)
  • Table 13. U.S. Toxicity Testing Outsourcing, by Glp, 2018 - 2030 (USD Million)
  • Table 14. U.S. Toxicity Testing Outsourcing, by End Use, 2018 - 2030 (USD Million)
  • Table 15. Canada Toxicity Testing Outsourcing, by Method, 2018 - 2030 (USD Million)
  • Table 16. Canada Toxicity Testing Outsourcing, by Glp, 2018 - 2030 (USD Million)
  • Table 17. Canada Toxicity Testing Outsourcing, by End Use, 2018 - 2030 (USD Million)
  • Table 18. Mexico Toxicity Testing Outsourcing, by Method, 2018 - 2030 (USD Million)
  • Table 19. Mexico Toxicity Testing Outsourcing, by Glp, 2018 - 2030 (USD Million)
  • Table 20. Mexico Toxicity Testing Outsourcing, by End Use, 2018 - 2030 (USD Million)
  • Table 21. Europe Toxicity Testing Outsourcing, by Country, 2018 - 2030 (USD Million)
  • Table 22. Europe Toxicity Testing Outsourcing, by Method, 2018 - 2030 (USD Million)
  • Table 23. Europe Toxicity Testing Outsourcing, by Glp, 2018 - 2030 (USD Million)
  • Table 24. Europe Toxicity Testing Outsourcing, by End Use, 2018 - 2030 (USD Million)
  • Table 25. UK Toxicity Testing Outsourcing, by Method, 2018 - 2030 (USD Million)
  • Table 26. UK Toxicity Testing Outsourcing, by Glp, 2018 - 2030 (USD Million)
  • Table 27. UK Toxicity Testing Outsourcing, by End Use, 2018 - 2030 (USD Million)
  • Table 28. Germany Toxicity Testing Outsourcing, by Method, 2018 - 2030 (USD Million)
  • Table 29. Germany Toxicity Testing Outsourcing, by Glp, 2018 - 2030 (USD Million)
  • Table 30. Germany Toxicity Testing Outsourcing, by End Use, 2018 - 2030 (USD Million)
  • Table 31. France Toxicity Testing Outsourcing, by Method, 2018 - 2030 (USD Million)
  • Table 32. France Toxicity Testing Outsourcing, by Glp, 2018 - 2030 (USD Million)
  • Table 33. France Toxicity Testing Outsourcing, by End Use, 2018 - 2030 (USD Million)
  • Table 34. Italy Toxicity Testing Outsourcing, by Method, 2018 - 2030 (USD Million)
  • Table 35. Italy Toxicity Testing Outsourcing, by Glp, 2018 - 2030 (USD Million)
  • Table 36. Italy Toxicity Testing Outsourcing, by End Use, 2018 - 2030 (USD Million)
  • Table 37. Spain Toxicity Testing Outsourcing, by Method, 2018 - 2030 (USD Million)
  • Table 38. Spain Toxicity Testing Outsourcing, by Glp, 2018 - 2030 (USD Million)
  • Table 39. Spain Toxicity Testing Outsourcing, by End Use, 2018 - 2030 (USD Million)
  • Table 40. Denmark Toxicity Testing Outsourcing, by Method, 2018 - 2030 (USD Million)
  • Table 41. Denmark Toxicity Testing Outsourcing, by Glp, 2018 - 2030 (USD Million)
  • Table 42. Denmark Toxicity Testing Outsourcing, by End Use, 2018 - 2030 (USD Million)
  • Table 43. Sweden Toxicity Testing Outsourcing, by Method, 2018 - 2030 (USD Million)
  • Table 44. Sweden Toxicity Testing Outsourcing, by Glp, 2018 - 2030 (USD Million)
  • Table 45. Sweden Toxicity Testing Outsourcing, by End Use, 2018 - 2030 (USD Million)
  • Table 46. Norway Toxicity Testing Outsourcing, by Method, 2018 - 2030 (USD Million)
  • Table 47. Norway Toxicity Testing Outsourcing, by Glp, 2018 - 2030 (USD Million)
  • Table 48. Norway Toxicity Testing Outsourcing, by End Use, 2018 - 2030 (USD Million)
  • Table 49. Asia Pacific Toxicity Testing Outsourcing, by Country, 2018 - 2030 (USD Million)
  • Table 50. Asia Pacific Toxicity Testing Outsourcing, by Method, 2018 - 2030 (USD Million)
  • Table 51. Asia Pacific Toxicity Testing Outsourcing, by Glp, 2018 - 2030 (USD Million)
  • Table 52. Asia Pacific Toxicity Testing Outsourcing, by End Use, 2018 - 2030 (USD Million)
  • Table 53. Japan Toxicity Testing Outsourcing, by Method, 2018 - 2030 (USD Million)
  • Table 54. Japan Toxicity Testing Outsourcing, by Glp, 2018 - 2030 (USD Million)
  • Table 55. Japan Toxicity Testing Outsourcing, by End Use, 2018 - 2030 (USD Million)
  • Table 56. China Toxicity Testing Outsourcing, by Method, 2018 - 2030 (USD Million)
  • Table 57. China Toxicity Testing Outsourcing, by Glp, 2018 - 2030 (USD Million)
  • Table 58. China Toxicity Testing Outsourcing, by End Use, 2018 - 2030 (USD Million)
  • Table 59. India Toxicity Testing Outsourcing, by Method, 2018 - 2030 (USD Million)
  • Table 60. India Toxicity Testing Outsourcing, by Glp, 2018 - 2030 (USD Million)
  • Table 61. India Toxicity Testing Outsourcing, by End Use, 2018 - 2030 (USD Million)
  • Table 62. Thailand Toxicity Testing Outsourcing, by Method, 2018 - 2030 (USD Million)
  • Table 63. Thailand Toxicity Testing Outsourcing, by Glp, 2018 - 2030 (USD Million)
  • Table 64. Thailand Toxicity Testing Outsourcing, by End Use, 2018 - 2030 (USD Million)
  • Table 65. South Korea Toxicity Testing Outsourcing, by Method, 2018 - 2030 (USD Million)
  • Table 66. South Korea Toxicity Testing Outsourcing, by Glp, 2018 - 2030 (USD Million)
  • Table 67. South Korea Toxicity Testing Outsourcing, by End Use, 2018 - 2030 (USD Million)
  • Table 68. Australia Toxicity Testing Outsourcing, by Method, 2018 - 2030 (USD Million)
  • Table 69. Australia Toxicity Testing Outsourcing, by Glp, 2018 - 2030 (USD Million)
  • Table 70. Australia Toxicity Testing Outsourcing, by End Use, 2018 - 2030 (USD Million)
  • Table 71. Latin America Toxicity Testing Outsourcing, by Country, 2018 - 2030 (USD Million)
  • Table 72. Latin America Toxicity Testing Outsourcing, by Method, 2018 - 2030 (USD Million)
  • Table 73. Latin America Toxicity Testing Outsourcing, by Glp, 2018 - 2030 (USD Million)
  • Table 74. Latin America Toxicity Testing Outsourcing, by End Use, 2018 - 2030 (USD Million)
  • Table 75. Brazil Toxicity Testing Outsourcing, by Method, 2018 - 2030 (USD Million)
  • Table 76. Brazil Toxicity Testing Outsourcing, by Glp, 2018 - 2030 (USD Million)
  • Table 77. Brazil Toxicity Testing Outsourcing, by End Use, 2018 - 2030 (USD Million)
  • Table 78. Argentina Toxicity Testing Outsourcing, by Method, 2018 - 2030 (USD Million)
  • Table 79. Argentina Toxicity Testing Outsourcing, by Glp, 2018 - 2030 (USD Million)
  • Table 80. Argentina Toxicity Testing Outsourcing, by End Use, 2018 - 2030 (USD Million)
  • Table 81. Middle East & Africa Toxicity Testing Outsourcing, by Country, 2018 - 2030 (USD Million)
  • Table 82. Middle East & Africa Toxicity Testing Outsourcing, by Method, 2018 - 2030 (USD Million)
  • Table 83. Middle East & Africa Toxicity Testing Outsourcing, by Glp, 2018 - 2030 (USD Million)
  • Table 84. Middle East & Africa Toxicity Testing Outsourcing, by End Use, 2018 - 2030 (USD Million)
  • Table 85. South Africa Toxicity Testing Outsourcing, by Method, 2018 - 2030 (USD Million)
  • Table 86. South Africa Toxicity Testing Outsourcing, by Glp, 2018 - 2030 (USD Million)
  • Table 87. South Africa Toxicity Testing Outsourcing, by End Use, 2018 - 2030 (USD Million)
  • Table 88. Saudi Arabia Toxicity Testing Outsourcing, by Method, 2018 - 2030 (USD Million)
  • Table 89. Saudi Arabia Toxicity Testing Outsourcing, by Glp, 2018 - 2030 (USD Million)
  • Table 90. Saudi Arabia Toxicity Testing Outsourcing, by End Use, 2018 - 2030 (USD Million)
  • Table 91. UAE Toxicity Testing Outsourcing, by Method, 2018 - 2030 (USD Million)
  • Table 92. UAE Toxicity Testing Outsourcing, by Glp, 2018 - 2030 (USD Million)
  • Table 93. UAE Toxicity Testing Outsourcing, by End Use, 2018 - 2030 (USD Million)
  • Table 94. Kuwait Toxicity Testing Outsourcing, by Method, 2018 - 2030 (USD Million)
  • Table 95. Kuwait Toxicity Testing Outsourcing, by Glp, 2018 - 2030 (USD Million)
  • Table 96. Kuwait Toxicity Testing Outsourcing, by End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain-based sizing & forecasting
  • Fig. 7 QFD modelling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Toxicity Testing Outsourcing Market revenue, 2018 - 2030 (USD Million)
  • Fig. 10 Toxicity Testing Outsourcing Market snapshot
  • Fig. 11 Toxicity Testing Outsourcing Market driver impact
  • Fig. 12 Toxicity Testing Outsourcing Market restraint impact
  • Fig. 13 Toxicity Testing Outsourcing Market: Method takeaways (USD Million)
  • Fig. 14 Toxicity Testing Outsourcing Market: Method movement analysis
  • Fig. 15 In vitro market, 2018 - 2030 (USD Million)
  • Fig. 16 In vivo market, 2018 - 2030 (USD Million)
  • Fig. 17 Toxicity Testing Outsourcing Market: Glp takeaways (USD Million)
  • Fig. 18 Toxicity Testing Outsourcing Market: Glp movement analysis
  • Fig. 19 GLP market, 2018 - 2030 (USD Million)
  • Fig. 20 Non-GLP market, 2018 - 2030 (USD Million)
  • Fig. 21 Toxicity Testing Outsourcing Market: End use takeaways (USD Million)
  • Fig. 22 Toxicity Testing Outsourcing Market: End use movement analysis
  • Fig. 23 Pharmaceutical and biopharmaceutical companies market, 2018 - 2030 (USD Million)
  • Fig. 24 Academic and research institutes market, 2018 - 2030 (USD Million)
  • Fig. 25 Others market, 2018 - 2030 (USD Million)
  • Fig. 26 Regional marketplace: Key takeaways
  • Fig. 27 Regional outlook, 2024 & 2030
  • Fig. 28 North America Toxicity Testing Outsourcing Market, 2018 - 2030 (USD Million)
  • Fig. 29 U.S. Toxicity Testing Outsourcing Market, 2018 - 2030 (USD Million)
  • Fig. 30 Canada Toxicity Testing Outsourcing Market, 2018 - 2030 (USD Million)
  • Fig. 31 Mexico Toxicity Testing Outsourcing Market, 2018 - 2030 (USD Million)
  • Fig. 32 Europe Toxicity Testing Outsourcing Market, 2018 - 2030 (USD Million)
  • Fig. 33 UK Toxicity Testing Outsourcing Market, 2018 - 2030 (USD Million)
  • Fig. 34 Germany Toxicity Testing Outsourcing Market, 2018 - 2030 (USD Million)
  • Fig. 35 France Toxicity Testing Outsourcing Market, 2018 - 2030 (USD Million)
  • Fig. 36 Italy Toxicity Testing Outsourcing Market, 2018 - 2030 (USD Million)
  • Fig. 37 Spain companion animal Health market, 2018 - 2030 (USD Million)
  • Fig. 38 Sweden Toxicity Testing Outsourcing Market, 2018 - 2030 (USD Million)
  • Fig. 39 Denmark Toxicity Testing Outsourcing Market, 2018 - 2030 (USD Million)
  • Fig. 40 Norway Toxicity Testing Outsourcing Market, 2018 - 2030 (USD Million)
  • Fig. 41 Asia Pacific Toxicity Testing Outsourcing Market, 2018 - 2030 (USD Million)
  • Fig. 42 Japan Toxicity Testing Outsourcing Market, 2018 - 2030 (USD Million)
  • Fig. 43 China Toxicity Testing Outsourcing Market, 2018 - 2030 (USD Million)
  • Fig. 44 India Toxicity Testing Outsourcing Market, 2018 - 2030 (USD Million)
  • Fig. 45 Thailand Toxicity Testing Outsourcing Market, 2018 - 2030 (USD Million)
  • Fig. 46 South Korea Toxicity Testing Outsourcing Market, 2018 - 2030 (USD Million)
  • Fig. 47 Australia Toxicity Testing Outsourcing Market, 2018 - 2030 (USD Million)
  • Fig. 48 Latin America Toxicity Testing Outsourcing Market, 2018 - 2030 (USD Million)
  • Fig. 49 Brazil Toxicity Testing Outsourcing Market, 2018 - 2030 (USD Million)
  • Fig. 50 Argentina Toxicity Testing Outsourcing Market, 2018 - 2030 (USD Million)
  • Fig. 51 Middle East & Africa Toxicity Testing Outsourcing Market, 2018 - 2030 (USD Million)
  • Fig. 52 South Africa Toxicity Testing Outsourcing Market, 2018 - 2030 (USD Million)
  • Fig. 53 Saudi Arabia Toxicity Testing Outsourcing Market, 2018 - 2030 (USD Million)
  • Fig. 54 UAE Toxicity Testing Outsourcing Market, 2018 - 2030 (USD Million)
  • Fig. 55 Kuwait Toxicity Testing Outsourcing Market, 2018 - 2030 (USD Million)
  • Fig. 56 Market participant categorization